Drug Shortage Report for HYPERTET S/D
| Report ID | 139131 |
| Drug Identification Number | 02230697 |
| Brand name | HYPERTET S/D |
| Common or Proper name | TETANUS IMMUNOGLOBULIN (HUMAN), SOLVENT DETERGENT TREATED |
| Company Name | GRIFOLS THERAPEUTICS LLC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | TETANUS IMMUNOGLOBULIN |
| Strength(s) | 250UNIT |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | 250 IU Syringe |
| ATC code | J06BB |
| ATC description | IMMUNOGLOBULINS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2021-05-11 |
| Actual start date | |
| Estimated end date | 2021-05-12 |
| Actual end date | 2021-05-11 |
| Shortage status | Resolved |
| Updated date | 2021-05-12 |
| Company comments | To ensure continuous supply while Grifols implements a planned manufacturing process update for this product, Grifols has received authorization from Health Canada to distribute HyperTET® S/D Lot No. T2MDE00023 that has a US label on its pre-filled syringe. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v14 | 2021-05-12 | English | Compare |
| v13 | 2021-05-11 | French | Compare |
| v12 | 2021-05-11 | English | Compare |
| v11 | 2021-05-11 | English | Compare |
| v10 | 2021-05-10 | French | Compare |
| v9 | 2021-05-10 | French | Compare |
| v8 | 2021-05-10 | English | Compare |
| v7 | 2021-05-10 | French | Compare |
| v6 | 2021-05-10 | English | Compare |
| v5 | 2021-05-10 | French | Compare |
| v4 | 2021-05-10 | French | Compare |
| v3 | 2021-05-10 | English | Compare |
| v2 | 2021-05-10 | English | Compare |
| v1 | 2021-05-10 | English | Compare |
Showing 1 to 14 of 14